By A Staff Reporter
Kathmandu, July 10: Eight hundred thousand doses of Vero Cell, a COVID-19 vaccine developed and manufactured by Sinopharm, China, were brought in Kathmandu Friday morning.
A wide body airplane, A 330, of the Nepal Airlines Corporation laden with 800,000 doses of Vero Cell landed in Kathmandu at 6:21 am this morning, informed Dipu Gwarchan, a pilot of the airplane.
The plane had flown to Beijing yesterday, July 8, to bring the vaccine. The vaccine has been purchased on the government-to-government (GtoG) basis. Altogether four million doses of Vero Cell are to be procured on this basis, and brought.
According to the schedule published earlier, remaining vaccine will be brought on July 15, July 16 and July 22.
Earlier, China had donated 2 million doses of Vero Cell to Nepal.
Nepal had also received 348 thousand doses of vaccine under COVAX while India had also provided 1.8 doses of Covishield as assistance.
A total of 4.248 million doses of anti-coronavirus vaccine have arrived in Nepal so far, according to the record of the Ministry of Health and Population.
So far, 2,611,807 people in Nepal have received the first dose of anti-coronavirus vaccine of which, 964,508 have already received their second jab, as per the Health Ministry.
Approximately 220 companies are listed in the Nepal Stock Exchange (NEPSE) by the end of the current fiscal year 2020/21. Share market capitalization has reached Rs. 4216 billion which is higher than the Gross Domestic Product (GDP) of the country.
In the current fiscal, SEBON has licensed the Citizen Stock Dealer Limited, a subsidiary of Citizen Investment Trust, to work as a stock dealer.
Speaking at the programme, Dr. Rewat Bahadur Karki, formar Chairman of the board, said that Stock market regulator should be more vigilant and strong to create safe environment for investment in the stock market.
He recommended to operate a second stock exchange in order to create competition in the market.